Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-01 | 136329 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2020-08-20 | 2021-01-28 | 122702 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2024-02-08 | 2024-04-05 | 218960 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-04-03 | 2017-05-10 | 5177 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-04-03 | 2017-10-24 | 5180 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2021-02-05 | 2021-02-11 | 133467 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2024-05-30 | 2025-02-21 | 229230 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2023-08-18 | 2023-10-04 | 202490 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195867 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-07-20 | 2023-10-04 | 199313 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2022-03-31 | 2022-08-19 | 157642 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-03 | 2022-12-08 | 161928 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-09 | 2023-01-18 | 162271 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2022-08-18 | 2025-04-25 | 167162 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2019-12-19 | 2020-03-05 | 101715 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-01-24 | 2020-02-13 | 104359 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-01-30 | 2020-04-09 | 104917 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-01-19 | 2023-01-26 | 181611 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-10-04 | 194080 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2020-07-09 | 2020-10-30 | 119886 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |
| TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256119 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256113 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256116 |